title: [Organism distribution and drug resistance in 7 cases of severe acute respiratory syndrome death patients with secondary bacteria infection].
abstract: OBJECTIVE
  To study the organism distribution and drug resistance of seven cases of severe acute respiratory syndrome (SARS) death patients with secondary bacterial infection.
  
  
  METHODS
  Thirty strains of bacteria from seven cases of SARS patients with secondary bacterial infection were classified and drug resistance was analyzed.
  
  
  RESULTS
  Seven cases of SARS death patients were all infected secondly and 5 cases were polyinfection. Twenty-four (31.5 percent) of 76 examed samples were positive. There were 30 strains of bacteria isolated from seven cases of SARS death patients with secondary bacterial infection. There were 9 strains of Gram negative bacteria (GNB), 8 strains of Gram positive cocci (GPC), and 13 strains of Fungi. The sensitive rate of vancomycin to GPC was 100.0 percent. The sensitive rate of imipenem, piperacillin/tazobactan was 100.0 percent, 44.5 percent, respectively. The sensitive rate of fluconazole to fungi was 92.4 percent.
  
  
  CONCLUSIONS
  SARS patients are consitive to be infected secondary bacteria. Secondary bacteria infection is one of important reason of death.
authors.affiliation: Clinical Laboratory Ersha Island Branch, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510105, Guangdong, China.
authors.forename: Jian-bing
authors.initials: JB
authors.lastname: Wang
authors.forename: Ning
authors.initials: N
authors.lastname: Xu
authors.forename: Han-zhen
authors.initials: HZ
authors.lastname: Shi
authors.forename: Xian-zhang
authors.initials: XZ
authors.lastname: Huang
authors.forename: Lin
authors.initials: L
authors.lastname: Lin
mesh_terms: D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000382:microbiology* / Q000401:mortality; D002423:Cause of Death; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D045169:Severe Acute Respiratory Syndrome / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*